United Kingdom and Netherlands · market
Daily Dive | A UK cannabis assessment and a Dutch batch certificate tell buyers different things
The commercial question
Boots Online Doctor launched SureLeaf on November 16. An eligible patient can begin online, a specialist carries out an assessment and a second consultant participates in reviewing any proposed prescription. The launch establishes that the channel exists. A wholesaler still needs to know how many prescriptions are filled and how often patients return. Boots plans an initial clinical review after 28 days. The review alone cannot tell us how much product was dispensed.
For buyers
The Dutch Office of Medicinal Cannabis lists two November 11 release certificates for Cannabis Flos Bedrocan, batches 26H10EY26I02 and 26H24EY26I16. If a supplier offers either batch, match its identifier against the certificate and ask for the quantity allocated to your account. A written allocation and dispatch date are stronger evidence for a delivery forecast than a certificate on its own.
For sellers
In Britain, a distributor evaluating the Boots launch can ask which products the channel uses, who manages replenishment and when dispensing data might become available. In the Netherlands, a seller can answer a narrower question immediately by identifying the lot, available quantity and delivery window. Those two sales conversations require different documents.
What the evidence does not establish
Boots disclosed no order volumes, dispensing totals or supplier names. The Dutch register gives no buyer-specific allocation or export schedule. The two announcements use different units of observation, so they cannot be combined into a single demand estimate.
What to investigate next
For the next UK update, look for first prescriptions filled and repeat dispensing. For the Dutch update, check subsequent release certificates and supplier confirmations for the named lots. Raise the forecast only when new evidence supports the particular channel or shipment.